Financhill
Back

Cadrenal Therapeutics Quote, Financials, Valuation and Earnings

Sell
26

CVKD
Cadrenal Therapeutics

Last Price:
0.41
Seasonality Move:
-45.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Cadrenal Therapeutics Price Quote

$0.41
0.00 (-4.67%)
(Updated: May 18, 2024 at 5:40 AM ET)

Cadrenal Therapeutics Key Stats

Sell
26
Cadrenal Therapeutics (CVKD) is a Sell

Day range:
$0.41 - $0.46
52-week range:
$0.36 - $3.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.06%

Volume:
171.1K
Avg. volume:
384.2K
1-year change:
-71.06%
Market cap:
$6.6M
Revenue:
$0
EPS:
$-0.31

How Much Does Cadrenal Therapeutics Make?

Data Unavailable

Is Cadrenal Therapeutics Growing As A Company?

Data Unavailable

Cadrenal Therapeutics Stock Price Performance

What Is Cadrenal Therapeutics 52-Week High & Low?

Cadrenal Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cadrenal Therapeutics?

Is Cadrenal Therapeutics Cash Flow Positive?

  • What Is CVKD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4M
  • What Is Cadrenal Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $6.5M
  • What Is Cadrenal Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Cadrenal Therapeutics Return On Invested Capital

Data Unavailable

Cadrenal Therapeutics Earnings Date & Stock Price

Cadrenal Therapeutics Competitors

Cadrenal Therapeutics Dividend Yield

Data Unavailable

Cadrenal Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.11%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.50
Upside from Last Price: 751.58%

Major Shareholders

  • How many CVKD shares are owned by institutional investors?
    622.7K CVKD shares are owned by institutional investors
  • How many CVKD shares are owned by insiders?
    4.5M CVKD shares are owned by insiders